Robert J. Behrens

1.2k total citations
40 papers, 817 citations indexed

About

Robert J. Behrens is a scholar working on Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Robert J. Behrens has authored 40 papers receiving a total of 817 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 11 papers in Pathology and Forensic Medicine and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Robert J. Behrens's work include Colorectal Cancer Treatments and Studies (11 papers), Genetic factors in colorectal cancer (10 papers) and Cancer Treatment and Pharmacology (8 papers). Robert J. Behrens is often cited by papers focused on Colorectal Cancer Treatments and Studies (11 papers), Genetic factors in colorectal cancer (10 papers) and Cancer Treatment and Pharmacology (8 papers). Robert J. Behrens collaborates with scholars based in United States, Germany and Myanmar. Robert J. Behrens's co-authors include C. David James, Kurt A. Jaeckle, John C. Krauss, Bernd W. Scheithauer, Patrick J. Flynn, Jan C. Buckner, Wenting Wu, Daniel A. Nikcevich, Joon H. Uhm and Paul Schaefer and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

In The Last Decade

Robert J. Behrens

35 papers receiving 804 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert J. Behrens United States 14 484 206 183 144 143 40 817
Bin Meng China 18 334 0.7× 245 1.2× 151 0.8× 141 1.0× 186 1.3× 62 814
Pia Klausen Denmark 16 387 0.8× 246 1.2× 105 0.6× 96 0.7× 118 0.8× 33 928
Émpar Mayordomo Spain 12 428 0.9× 277 1.3× 112 0.6× 153 1.1× 264 1.8× 16 829
Martin Poleski United States 12 548 1.1× 357 1.7× 176 1.0× 193 1.3× 192 1.3× 18 1.2k
Miguel A. Cruz Spain 11 250 0.5× 277 1.3× 315 1.7× 154 1.1× 91 0.6× 13 724
Robert N. Raju United States 16 667 1.4× 284 1.4× 127 0.7× 178 1.2× 241 1.7× 30 985
Karen A. Cadoo United States 19 365 0.8× 241 1.2× 106 0.6× 162 1.1× 211 1.5× 74 868
Vittoria Martin Switzerland 14 344 0.7× 196 1.0× 268 1.5× 84 0.6× 170 1.2× 30 652
Giovanni Citterio Italy 15 339 0.7× 251 1.2× 193 1.1× 85 0.6× 155 1.1× 37 853
Hui‐Lan Rao China 20 664 1.4× 259 1.3× 298 1.6× 142 1.0× 218 1.5× 44 1.1k

Countries citing papers authored by Robert J. Behrens

Since Specialization
Citations

This map shows the geographic impact of Robert J. Behrens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert J. Behrens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert J. Behrens more than expected).

Fields of papers citing papers by Robert J. Behrens

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert J. Behrens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert J. Behrens. The network helps show where Robert J. Behrens may publish in the future.

Co-authorship network of co-authors of Robert J. Behrens

This figure shows the co-authorship network connecting the top 25 collaborators of Robert J. Behrens. A scholar is included among the top collaborators of Robert J. Behrens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert J. Behrens. Robert J. Behrens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Hershman, Dawn L., Aasthaa Bansal, Sean D. Sullivan, et al.. (2022). A Pragmatic Cluster-Randomized Trial of a Standing Order Entry Intervention for Colony-Stimulating Factor Use Among Patients at Intermediate Risk for Febrile Neutropenia. Journal of Clinical Oncology. 41(3). 590–598. 3 indexed citations
3.
Yoon, Harry H., Fang‐Shu Ou, Gamini S. Soori, et al.. (2021). Induction versus no induction chemotherapy before neoadjuvant chemoradiotherapy and surgery in oesophageal adenocarcinoma: a multicentre randomised phase II trial (NCCTG N0849 [Alliance]). European Journal of Cancer. 150. 214–223. 13 indexed citations
4.
Kulkarni, Amit, Rahul Kanwar, Peter Beyerlein, et al.. (2015). Association of the Charcot–Marie–Tooth disease gene ARHGEF10 with paclitaxel induced peripheral neuropathy in NCCTG N08CA (Alliance). Journal of the Neurological Sciences. 357(1-2). 35–40. 39 indexed citations
5.
6.
7.
Alberts, Steven R., Tiffany M. Yu, Robert J. Behrens, et al.. (2014). Comparative Economics of a 12-Gene Assay for Predicting Risk of Recurrence in Stage II Colon Cancer. PharmacoEconomics. 32(12). 1231–1243. 13 indexed citations
8.
Siziopikou, Kalliopi P., Stewart Anderson, Melody Cobleigh, et al.. (2013). Preliminary results of centralized HER2 testing in ductal carcinoma in situ (DCIS): NSABP B-43. Breast Cancer Research and Treatment. 142(2). 415–421. 45 indexed citations
9.
Brown, Lindsay C., Pamela J. Atherton, M.A. Neben-Wittich, et al.. (2013). Assessment of long-term rectal function in patients who received pelvic radiotherapy: a pooled North Central Cancer Treatment Group trial analysis, N09C1. Supportive Care in Cancer. 21(10). 2869–2877. 4 indexed citations
10.
Sideras, Kostandinos, Amylou C. Dueck, Timothy J. Hobday, et al.. (2012). North Central Cancer Treatment Group (NCCTG) N0537: Phase II Trial of VEGF-Trap in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and/or a Taxane. Clinical Breast Cancer. 12(6). 387–391. 11 indexed citations
11.
Kim, George P., Nathan R. Foster, Michael G. Haddock, et al.. (2012). North Central Cancer Treatment Group phase II study of panitumumab (Pmab), chemotherapy, and external beam radiation (Chemo-RT) in patients with locally advanced (LA) pancreatic cancer.. Journal of Clinical Oncology. 30(4_suppl). 271–271. 2 indexed citations
12.
Stella, Philip J., Shauna L. Hillman, Kendrith M. Rowland, et al.. (2011). Exploring Therapeutic Decisions in Elderly Patients with Non-Small Cell Lung Cancer: Results and Conclusions from North Central Cancer Treatment Group Study N0222. Cancer Investigation. 29(4). 266–271. 4 indexed citations
13.
Uhm, Joon H., Karla V. Ballman, Wenting Wu, et al.. (2010). Phase II Evaluation of Gefitinib in Patients With Newly Diagnosed Grade 4 Astrocytoma: Mayo/North Central Cancer Treatment Group Study N0074. International Journal of Radiation Oncology*Biology*Physics. 80(2). 347–353. 134 indexed citations
14.
Kottschade, Lisa A., Vera J. Suman, Thomas Amatruda, et al.. (2010). A phase II trial of nab‐paclitaxel (ABI‐007) and carboplatin in patients with unresectable stage IV melanoma. Cancer. 117(8). 1704–1710. 79 indexed citations
15.
Wagner, Dorothea, Markus Moehler, Harald Schmalenberg, et al.. (2009). Gemcitabine, oxaliplatin and 5-FU in advanced bile duct and gallbladder carcinoma: two parallel, multicentre phase-II trials. British Journal of Cancer. 101(11). 1846–1852. 42 indexed citations
16.
Behrens, Robert J., et al.. (2008). Fatale Folgen einer Fructose-Infusion bei undiagnostizierter Fructose-Intoleranz. DMW - Deutsche Medizinische Wochenschrift. 113(23). 945–947. 1 indexed citations
17.
Toubaji, Antoun, Maurizio Provenzano, Robert J. Behrens, et al.. (2008). Pilot study of mutant ras peptide-based vaccine as an adjuvant treatment in pancreatic and colorectal cancers. Cancer Immunology Immunotherapy. 57(9). 1413–1420. 99 indexed citations
18.
Behrens, Robert J., et al.. (2008). Eosinophiles kationisches Protein bei einer 39jährigen Patientin mit Churg-Strauss-Syndrom. DMW - Deutsche Medizinische Wochenschrift. 123(01/02). 6–11.
19.
20.
Behrens, Robert J., et al.. (2001). Langerhans Cell Histiocytosis of the Thyroid: A Report of Two Cases and Review of the Literature. Thyroid. 11(7). 697–705. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bin Meng Breakdown of academic impact, for papers by Pia Klausen Breakdown of academic impact, for papers by Émpar Mayordomo Breakdown of academic impact, for papers by Martin Poleski Breakdown of academic impact, for papers by Miguel A. Cruz Breakdown of academic impact, for papers by Robert N. Raju Breakdown of academic impact, for papers by Karen A. Cadoo Breakdown of academic impact, for papers by Vittoria Martin Breakdown of academic impact, for papers by Giovanni Citterio Breakdown of academic impact, for papers by Hui‐Lan Rao
Rankless by CCL
2026